Skip to Main Content

Paper Details

Empagliflozin and Decreased Risk of Nephrolithiasis: A Potential New Role for SGLT2 Inhibition?
J Clin Endocrinol Metab
11
2022
Author NameAffiliation
Bernard ZinmanLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
  • 1 - 1

Datasets

Release 1.2